DITROPAN XL® (Ortho-McNeil)
(oxybutynin chloride)
|
Category:
Description:
Indications:
-
Irritable bladder
-
Urgency incontinence
Contraindications:
- Urinary retention
- Gastric retention and other severe decreased gastrointestinal
motility condition
- Uncontrolled narrow-angle glaucoma and in patients who are at risk
for these conditions.
- hypersensitivity to the medication
Precautions:
-
Pregnancy category B
- Used with caution in patients with hepatic or renal impairment and
in patients with myasthenia gravis due to the risk of symptom
aggravation.
- Bladder outflow ob-struction because of the risk of urinary
retention
- Gastrointestinal obstructive disorders
- uUcerative colitis and intestinal atony.
- GI reflux
- Those taking drugs (such as bisphosphonates) that can cause or
exacerbate esophagitis.
Adverse
Reactions (Side Effects):
-
General: abdominal pain, dry nasal
and sinus mucous membranes, accidental injury, back pain, flu syndrome
-
Oral: Dry mouth
-
Cardiovascular: hypertension,
palpitation, vasodilatation; Digestive: flatulence, GE reflux,
nausea
-
Musculoskeletal: arthritis
-
Nervous: insomnia, nervousness,
confusion
-
Respiratory: upper respiratory
tract infection, cough, sinusitis, bronchitis, pharyngitis
-
Skin: dry skin, rash
-
Urogenital: impaired urination
(hesitancy), increased post void residual volume, urinary retention,
cystitis.
|
Dosage:
Must be swallowed whole with the aid of liquids, and must not be
chewed, divided, or crushed.
May be administered with or without food.
Adults:
- 5 or 10 mg once daily at approximately the same time each day.
- Dosage may be adjusted in 5-mg increments to achieve a balance of
efficacy and tolerability (up to a maximum of 30 mg/day).
- Dose adjustment may proceed at weekly intervals.
|
|
|
|
The information contained here is an
abbreviated summary. For more detailed and complete information, consult the
manufacturer's product information sheets or standard textbooks
Source: Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300
This information is provided by The Brookside Associates. The Brookside
Associates, LLC. is a private organization, not affiliated with any governmental
agency. The opinions presented here are those of the author and do not
necessarily represent the opinions of the Brookside Associates or the Department
of Defense. The presence of any advertising on these pages does not constitute
an endorsement of that product or service by either the US Department of Defense
or the Brookside Associates. All material presented here is unclassified.
C. 2009, 2014, All Rights Reserved
|
|